| Patents for C12P 21 - Preparation of peptides or proteins (112,499) |
|---|
| 02/02/2006 | US20060025576 Multivalent antibodies and uses therefor |
| 02/02/2006 | US20060025575 Hybridoma cell line producing monoclonal antibodies to bind to, to detect and qualitatively and quantitatively measure the presence of epitopes of prion proteins; neurodegenerative diseases of the central nervous system |
| 02/02/2006 | US20060025574 32 human secreted proteins |
| 02/02/2006 | US20060025573 Reducing the immunogenicity of fusion proteins |
| 02/02/2006 | US20060025572 Mammalian cell surface antigens; related reagents |
| 02/02/2006 | US20060025570 Megakaryocyte stimulating factors |
| 02/02/2006 | US20060025371 Methods of inhibiting COX-2 |
| 02/02/2006 | US20060025369 Methods of inhibiting manganese-containing superoxide dismutase 2 (MnSOD) |
| 02/02/2006 | US20060025362 Guanylate binding protein (GBP-1) as inhibitor of cell proliferation and molecular marker for the determination of the stage of cellular differentiation |
| 02/02/2006 | US20060025360 Human cervical cancer protooncogene and protein encoded therein |
| 02/02/2006 | US20060025341 Isolated polynucleotide encoding inhibin-related proteins for treating cancer of epithelial, testicular, ovarian, prostate; biodrug protein; activin binding activity; hormone inhibitor; muscle regeneration |
| 02/02/2006 | US20060024809 Ceramidase gene |
| 02/02/2006 | US20060024808 Covalent tethering of functional groups to proteins and substrates therefor |
| 02/02/2006 | US20060024807 Kinase nucleic acids and polypeptides encoded by these nucleic acids; kinase inhibiitor design and indentifying inhibitors |
| 02/02/2006 | US20060024805 Disintegrin homologs |
| 02/02/2006 | US20060024804 Isoforms isolated and purified from mammalian colostrum |
| 02/02/2006 | US20060024800 Method of modulating the activity of functional immune molecules |
| 02/02/2006 | US20060024795 Interferon-Like molecules and uses thereof |
| 02/02/2006 | US20060024794 Novel methods for production of di-chain botulinum toxin |
| 02/02/2006 | US20060024793 Method of producing recombinant antithrombin III composition |
| 02/02/2006 | US20060024792 G-protein coupled receptors |
| 02/02/2006 | US20060024790 Recombinant cage-like protein, method for producing the same, precious metal-recombinant cage-like protein complex, method for producing the same and recombinant DNA |
| 02/02/2006 | US20060024789 Thermostable T1 lipase gene |
| 02/02/2006 | US20060024788 Inducible alphaviral gene expression system |
| 02/02/2006 | US20060024787 Chimp trace amine associated receptors and polypeptides |
| 02/02/2006 | US20060024786 WASP and N-WASP constructs and methods of expressing such constructs |
| 02/02/2006 | US20060024785 Having mutations in the Kinase domain region (KDR) and/or the FMS-like Tyrosine-Kinase region (FLT-1), said variants exhibiting modified binding characteristics at said regions compared with native VEGF; stimulates vasculogenesis or angiogenesis; wound healing |
| 02/02/2006 | US20060024784 Phenol oxidizing enzymes |
| 02/02/2006 | US20060024783 BMP10 propeptides and related methods |
| 02/02/2006 | US20060024782 Production of a monoclonal antibody in a heterokaryon filamentous fungus or in a filamentous fungal host cell |
| 02/02/2006 | US20060024781 Detection of truncation mutations by mass spectrometry |
| 02/02/2006 | US20060024780 Isolation; cloning; hybrid anticancer agents; protein genetic mapping of human chromosome |
| 02/02/2006 | US20060024779 Glycosulfopeptide inhibitors of leukocyte rolling and methods of use thereof |
| 02/02/2006 | US20060024778 Method for enzymatic production of GLP-2(1-33) and GLP-2(1-34) peptides |
| 02/02/2006 | US20060024777 preparation of non-bitter protein hydrolyzate with defined degree of hydrolysis of 30-33% and an arginine:lysine ratio of at least 5.5:1 from groundnut protein isolate, especially using fungal protease from Aspergillus |
| 02/02/2006 | US20060024773 Method for measuring intracellular gene transcription using blue luciferase from dinoflagellate |
| 02/02/2006 | US20060024772 Parathyroid hormone antibodies and related methods |
| 02/02/2006 | US20060024764 Proteins producing an altered immunogenic response and methods of making the same |
| 02/02/2006 | US20060024761 Protein biopolymer markers predictive of alzheimer's disease |
| 02/02/2006 | US20060024760 Human brain carboxypeptidase B |
| 02/02/2006 | US20060024747 Comprises nucleotide sequences coding nitrillase and amidase for transformation and propagation of microorganism capable of catalyzing hydration of certain nitrites to corresponding amides and amides to corresponding carboxylic acids |
| 02/02/2006 | US20060024739 C. elegans gro-1 gene |
| 02/02/2006 | US20060024730 TF binding compounds |
| 02/02/2006 | US20060024729 Mechanosensitive mammalian potassium channels activatable by polyunsaturated fatty acids and the use of said channels in drug screening |
| 02/02/2006 | US20060024728 GM-CSF and/or defensin protein expression regulators in epithelial cells comprising ETS transcription factor or gene encoding the same |
| 02/02/2006 | US20060024726 Position dependent recognition of GNN nucleotide triplets by zinc fingers |
| 02/02/2006 | US20060024708 Porcine sulfotransferase 2A1 polynucleotide sequence, protein, and methods of use for same |
| 02/02/2006 | US20060024704 Detection of markers in nascent proteins |
| 02/02/2006 | US20060024696 Nucleic acid and polypeptide sequences from Lawsonia intracellularis and methods of using |
| 02/02/2006 | US20060024689 Process for the purification of recombinant proteins from complex media and purified proteins obtained thereby |
| 02/02/2006 | US20060024683 Transcription factor of MHC class II genes, substances capable of inhibiting this transcription factor and medical uses of these substances |
| 02/02/2006 | US20060024680 A bicistronic DNA construct containing IRES of enterovirus and an amount of amantadine that inhibits the IRES-dependent translation activity in a dose-dependent manner without interfering the CAP-dependent translation |
| 02/02/2006 | US20060024679 Method for predicting the expression efficiency in cell-free expression systems |
| 02/02/2006 | US20060024670 Influenza virus vaccine composition and methods of use |
| 02/02/2006 | US20060024668 Coronavirus, nucleic acid, protein, and methods for the generation of vaccine, medicaments and diagnostics |
| 02/02/2006 | US20060024666 Humanized antibodies against the venezuelan equine encephalitis virus |
| 02/02/2006 | US20060024318 Vaccination with immuno-isolated cells producing an immunomodulator |
| 02/02/2006 | US20060024316 Prostatic cancer vaccine |
| 02/02/2006 | US20060024313 Agents that disrupt dimer formation in DPP-IV family of prolyl dipeptidases |
| 02/02/2006 | US20060024312 Methods for enhancing learning and memory |
| 02/02/2006 | US20060024305 Camp-regulated phosphoprotein for diagnostic and therapeutic use in neurodegenerative diseases |
| 02/02/2006 | US20060024304 Immunoglobulins comprising predominantly a Man5GlcNAc2 glycoform |
| 02/02/2006 | US20060024301 Prostate-specific polypeptides and fusion polypeptides thereof |
| 02/02/2006 | US20060024299 Human osteoclast derived cathepsin |
| 02/02/2006 | US20060024297 Tie complex binding proteins |
| 02/02/2006 | US20060024293 Antibody for use in the treatment and prevention of sepsis, infections, autoimmune and graft-versus-host diseases; biodegradable, biocompatible polymer and human antibody, or an antigen-binding portion thereof, that dissociates from human TNF alpha |
| 02/02/2006 | US20060024291 Protocadherin materials and methods |
| 02/02/2006 | US20060024272 C-terminally truncated interferon |
| 02/02/2006 | DE19856463B4 Retrovirale, mit LCMV pseudotypisierte Hybrid-Vektoren Retroviral pseudotyped with LCMV hybrid vectors |
| 02/02/2006 | CA2616277A1 Urine markers for detection of bladder cancer |
| 02/01/2006 | EP1621635A2 Self-assembling recombinant HP16 papillomavirus capsid proteins |
| 02/01/2006 | EP1621633A2 Glycoproteins produced in plants with suppressed expression of beta 1, 2-xylosyltransferase |
| 02/01/2006 | EP1621627A2 Use of porcine gala (1,3) galactosyl transferase in xenograft therapies |
| 02/01/2006 | EP1621623A2 BASB029 polynucleotide(s) and polypeptides from Neisseria meningitis |
| 02/01/2006 | EP1621616A1 Human antihuman interleukin-18 antibody, fragment thereof and method of using the same |
| 02/01/2006 | EP1621613A1 Enzymatic reductions with dihydrogen via metal catalyzed cofactor regeneration |
| 02/01/2006 | EP1621556A1 Method of producing target protein, fused protein and gene thereof, partial sequence protein of intein and gene thereof, expression vector and transformant |
| 02/01/2006 | EP1621554A1 Immunoglobulins devoid of light chains |
| 02/01/2006 | EP1621553A1 Antibodies that inhibit transport activity of peptide transporters |
| 02/01/2006 | EP1621549A2 Compositions of fsh with high sialylation degree and their use for the preparation of medicinaments |
| 02/01/2006 | EP1621548A2 Polypeptides, CDNAs encoding the same and utilization thereof |
| 02/01/2006 | EP1621547A1 C of malarial pre-erythrocytic stage polypeptide molecules and lipids |
| 02/01/2006 | EP1621206A1 Chimeric cytokines and uses thereof |
| 02/01/2006 | EP1620125A2 Tolerance to graft following thymic reactivation |
| 02/01/2006 | EP1619952A2 Tolerance to graft prior to thymic regeneration |
| 02/01/2006 | EP1476563A4 Method for the recombination of genetic elements |
| 02/01/2006 | EP1410013A4 Compositions, kits, and methods for identification, assessment, prevention, and therapy of breast and ovarian cancer |
| 02/01/2006 | EP1200479B1 Multiple cytokine-antibody complexes |
| 02/01/2006 | EP1196566B1 Expression vectors and methods |
| 02/01/2006 | EP1179592B1 Proteins nectin-3 |
| 02/01/2006 | EP0922056B1 New fibrinogen binding protein originating from coagulase-negative staphylococcus |
| 02/01/2006 | EP0907736B1 Cc-type chemokines |
| 02/01/2006 | EP0835313B1 Omp26 antigen from haemophilus influenzae |
| 02/01/2006 | EP0264434B2 Detection of a unique chlamydia strain associated with acute respiratory disease |
| 02/01/2006 | CN1729298A Modified antibodies stably produced in milk and methods of producing same |
| 02/01/2006 | CN1728946A Method of obtaining viable human liver cells, including hepatic stem/progenitor cells |
| 02/01/2006 | CN1727492A Small peptide of II type protein, and preparation method |
| 02/01/2006 | CN1727480A Gene of expressing regeneration enhancement factor of recombined human liver in full lenght, and method for preparing regeneration enhancement factor of recombined human liver in full length, and usag |
| 02/01/2006 | CN1727479A Gene of expressing regeneration enhancement factor of recombined human liver in full length, and method for preparing regeneration enhancement factor of recombined human liver in full length, and usag |
| 02/01/2006 | CN1727359A Compound from catarrh mollase bacterial |